OMO-103

· Vall d'Hebron Institute of Oncology

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for OMO-103, covering 2024-04-25 to 2026-03-23. Get the full timeline:

Most recent: Clinical Trial Update: OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma [EARLY_Phase 1]